Laura Hansen

Investor Relations Contact at DENALI THERAPEUTICS INC.

Health Technology

Consumer Services

Profile

Laura G.
Hansen is currently Vice President-Investor Relations at Denali Therapeutics, Inc. since 2020.
Former positions include Vice President-Corporate Affairs at BlackThorn Therapeutics, Inc. (2019–2020), Vice President-Investor Relations at Aimmune Therapeutics, Inc. (2016–2019), Senior Director-Corporate Communications at Threshold Pharmaceuticals, Inc. (2012–2016), Director-Corporate Communications at Kyntra Bio, Inc. (2002–2012), and Director-Corporate Communications at Corvas International, Inc. (2001–2002).
Education includes undergraduate and doctorate degrees from The University of Texas at Austin.

Laura Hansen active positions

Companies	Position	Start
DENALI THERAPEUTICS INC.	Investor Relations Contact	01/09/2020

All active positions of Laura Hansen

Former positions of Laura Hansen

Companies	Position	End
BlackThorn Therapeutics, Inc. BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders	Corporate Officer/Principal	01/09/2020
AIMMUNE THERAPEUTICS, INC.	Investor Relations Contact	01/03/2019
Threshold Pharmaceuticals, Inc. Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Investor Relations Contact	01/02/2016
KYNTRA BIO, INC.	Public Communications Contact	01/07/2012
Corvas International, Inc. Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases	Public Communications Contact	01/07/2002

See the detail of Laura Hansen's experience

Training of Laura Hansen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Laura Hansen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Corvas International, Inc. Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases	Health Technology
Threshold Pharmaceuticals, Inc. Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology
FibroGen, Inc. FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs	Health Technology
The University of Texas at Austin The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aimmune Therapeutics, Inc. Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies	Health Technology
BlackThorn Therapeutics, Inc. BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders	Health Technology
Denali Therapeutics, Inc. Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases	Health Technology